In Shock | Neo Mokheti from scandal suffered from this illness in real life
Jerry Mofokeng is a prominent South African producer, director and actor popular for his role Bra Neo Mokheti on etv’s Scandal! He is no stranger to the small screen and his fame dates back to the 90s. With fame in Mzansi and yonder, let’s get to know more about this force worth reckoning with. Here are the facts.
The multi-award-winning actor was diagnosed with prostate cancer in 2019. He continued to keep his diagnosis a secret while he continued with what he loves, which is acting.
He went through five weeks of radiation therapy. To try to beat cancer he had to remain strong. He only share the news with his family.
After three weeks of treatment, the doctors informed him that all the symptoms of cancer had disappeared and he was in remission.
He has been through a lot and managed to survive. Neo Mokheti is cancer survivor.
Content created and supplied by: Outspoken_eyes (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More